BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26592450)

  • 1. Nucleic acid targeting: towards personalized therapy for head and neck cancer.
    Parsel SM; Grandis JR; Thomas SM
    Oncogene; 2016 Jun; 35(25):3217-26. PubMed ID: 26592450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma.
    Gong W; Xiao Y; Wei Z; Yuan Y; Qiu M; Sun C; Zeng X; Liang X; Feng M; Chen Q
    Oncotarget; 2017 Jan; 8(2):2141-2152. PubMed ID: 27924064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Therapy of Head and Neck Squamous Cell Carcinoma.
    Polverini PJ; D'Silva NJ; Lei YL
    J Dent Res; 2018 Jun; 97(6):614-621. PubMed ID: 29649374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR co-targeting strategies for head and neck cancer therapy.
    Wang Z; Valera JC; Zhao X; Chen Q; Gutkind JS
    Cancer Metastasis Rev; 2017 Sep; 36(3):491-502. PubMed ID: 28822012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leveraging Genomics for Head and Neck Cancer Treatment.
    Kemmer JD; Johnson DE; Grandis JR
    J Dent Res; 2018 Jun; 97(6):603-613. PubMed ID: 29420101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a personalized treatment of head and neck cancer.
    Gross AM; Cohen EE
    Am Soc Clin Oncol Educ Book; 2015; ():28-32. PubMed ID: 25993138
    [No Abstract]   [Full Text] [Related]  

  • 7. Incorporation of molecularly targeted agents in the primary treatment of squamous cell carcinomas of the head and neck.
    Bernier J
    Hematol Oncol Clin North Am; 2008 Dec; 22(6):1193-208, ix. PubMed ID: 19010268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting important pathways in head and neck cancer: from the bench to the clinic.
    Santos ES; Perez C; Donald CE; Raez LE
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1819-35. PubMed ID: 18983242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecularly targeted agents and immunotherapy for the treatment of head and neck squamous cell cancer (HNSCC).
    Azoury SC; Gilmore RC; Shukla V
    Discov Med; 2016 Jun; 21(118):507-16. PubMed ID: 27448787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic sequencing and precision medicine in head and neck cancers.
    Hoesli RC; Ludwig ML; Michmerhuizen NL; Rosko AJ; Spector ME; Brenner JC; Birkeland AC
    Eur J Surg Oncol; 2017 May; 43(5):884-892. PubMed ID: 28034498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging drugs for head and neck cancer.
    Wen Y; Grandis JR
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):313-29. PubMed ID: 25826749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of head and neck squamous cell carcinoma.
    Hardisson D
    Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):502-8. PubMed ID: 12736744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular targeted therapies in all histologies of head and neck cancers: an update.
    Razak AR; Siu LL; Le Tourneau C
    Curr Opin Oncol; 2010 May; 22(3):212-20. PubMed ID: 20173639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer.
    Le QT; Giaccia AJ
    Clin Cancer Res; 2003 Oct; 9(12):4287-95. PubMed ID: 14555497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
    Li D; Duan L; Freimuth P; O'Malley BW
    Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    Sacco AG; Cohen EE
    J Clin Oncol; 2015 Oct; 33(29):3305-13. PubMed ID: 26351341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of molecular diagnostics for personalized treatment of head and neck cancer: state of the art.
    Mes SW; Leemans CR; Brakenhoff RH
    Expert Rev Mol Diagn; 2016; 16(2):205-21. PubMed ID: 26620464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging era of personalized therapy in squamous cell carcinoma of the head and neck.
    Pryor DI; Solomon B; Porceddu SV
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):236-51. PubMed ID: 21884435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Personalized Cancer Care for Elderly Head and Neck Cancer Patients.
    Orlandi E; Bossi P
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):965-966. PubMed ID: 28602420
    [No Abstract]   [Full Text] [Related]  

  • 20. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
    Marur S; Forastiere AA
    Curr Opin Oncol; 2010 May; 22(3):206-11. PubMed ID: 20216313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.